+420 485 353 852|

cxi@tul.cz|

Staff


Project:

CeO2 Nanoparticles-assisted stem cell therapy

Registration number:TH70020001

Realization period:01.01. 2020 – 31.12. 2022

Leader at TUL:RNDr. Alena Ševců, Ph.D.

The main objective of CELLUX is to develop a novel pharmaceutical-based CeO2 eye drops to treat AMD (Age-related Macular Degeneration) that in combination with stem cell-based therapeutic strategies, will not only stop degeneration but restore vision.

General partners

Škoda AUTO
Česká Zbrojovka
Aquatest
Elmarco
FM Motol
Preciosa
UJV Group
Atrea
Innogy
Auren